Il-Yang Pharm Co. Ltd.

Clinical research activity is centered on Parkinson’s disease, with attention to the management of motor and non-motor symptoms associated with neurodegenerative disease.

• Parkinson’s disease treatment
• Neurological disorder therapeutics
• Movement disorder care

The sponsor’s trial portfolio reflects interest in therapies intended to address disease-related neurological impairment and clinical tolerability in central nervous system disorders.